Macrogenics (MGNX) Misses Q1 EPS by 11c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($1.08), $0.11 worse than the analyst estimate of ($0.97). Revenue for the quarter came in at $2.06 million versus the consensus estimate of $5.56 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• STMicroelectronics N.V. (STM) Misses Q1 EPS by 9c; offers Q2 outlook
• Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance